Literature DB >> 14985651

Asthma prevalence and control characteristics by race/ethnicity--United States, 2002.

.   

Abstract

During 1980-1999, asthma prevalence, morbidity, and mortality increased among U.S. adults. These annual rates were higher among certain racial/ethnic minority populations than among whites. In addition, racial/ethnic minority populations reported higher use of emergency departments (EDs) and doctors' offices for asthma treatment than whites. To assess asthma prevalence and asthma-control characteristics among racial/ethnic populations, CDC analyzed 2002 data from the Behavioral Risk Factor Surveillance System (BRFSS). This report summarizes the results of that analysis, which indicated that among the estimated 16 million (7.5%) U.S. adults with asthma, self-reported current asthma prevalence among racial/ethnic minority populations ranged from 3.1% to 14.5%, compared with 7.6% among whites. Comprehensive state-specific asthma surveillance data are necessary to identify disparities in asthma prevalence and asthma-control characteristics among racial/ethnic populations and to develop targeted public health interventions.

Mesh:

Year:  2004        PMID: 14985651

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  55 in total

1.  Asthma prevalence among US adults, 1998-2000: role of Puerto Rican ethnicity and behavioral and geographic factors.

Authors:  Deborah Rose; David M Mannino; Brian P Leaderer
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

Review 2.  Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma.

Authors:  Christine L M Joseph; L Keoki Williams; Dennis R Ownby; Jacquelyn Saltzgaber; Christine C Johnson
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

3.  Violence, abuse, and asthma in Puerto Rican children.

Authors:  Robyn T Cohen; Glorisa J Canino; Hector R Bird; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

4.  Impact of race on asthma treatment failures in the asthma clinical research network.

Authors:  Michael E Wechsler; Mario Castro; Erik Lehman; Vernon M Chinchilli; E Rand Sutherland; Loren Denlinger; Stephen C Lazarus; Stephen P Peters; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

5.  In utero supplementation with methyl donors enhances allergic airway disease in mice.

Authors:  John W Hollingsworth; Shuichiro Maruoka; Kathy Boon; Stavros Garantziotis; Zhuowei Li; John Tomfohr; Nathaniel Bailey; Erin N Potts; Gregory Whitehead; David M Brass; David A Schwartz
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  Disparities in the reporting and treatment of health conditions in children: an analysis of the Medical Expenditure Panel Survey.

Authors:  James P Guevara; David S Mandell; Anthony L Rostain; Huaqing Zhao; Trevor R Hadley
Journal:  Health Serv Res       Date:  2006-04       Impact factor: 3.402

7.  The extracellular matrix protein mindin regulates trafficking of murine eosinophils into the airspace.

Authors:  Zhuowei Li; Stavros Garantziotis; Wei Jia; Erin N Potts; Sikander Lalani; Zhi Liu; You-Wen He; W Michael Foster; John W Hollingsworth
Journal:  J Leukoc Biol       Date:  2008-09-25       Impact factor: 4.962

Review 8.  Self-regulation and women with asthma.

Authors:  Noreen M Clark; Melissa A Valerio; Zhongxin Molly Gong
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-06

9.  Reliability and validity of childhood asthma control test in a population of Chinese asthmatic children.

Authors:  Hsin-Hung Chen; Jiu-Yao Wang; Ren-Long Jan; Yi-Hsun Liu; Li-Fan Liu
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

10.  Aminophylline infusion for status asthmaticus in the pediatric critical care unit setting is independently associated with increased length of stay and time for symptom improvement.

Authors:  Abdallah R Dalabih; Steven A Bondi; Zena L Harris; Benjamin R Saville; Wenli Wang; Donald H Arnold
Journal:  Pulm Pharmacol Ther       Date:  2013-03-19       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.